Vancomycin Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Vancomycin clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Antibiotic Dosing in Pediatric Intensive Care

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+5 more
University Hospital, Ghent640 enrolled1 locationNCT02456974
Recruiting
Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+6 more
University Hospital, Ghent300 enrolled3 locationsNCT06426836
Recruiting
Not Applicable

Vancomycin Reduction Practices (VRP) in the NICU

VancomycinAntibiotic StewardshipNeonatal Sepsis, Late-Onset
Children's Hospital of Philadelphia13 enrolled13 locationsNCT06772675
Recruiting
Phase 2Phase 3

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Clostridium Difficile InfectionVancomycin Resistant Enterococci Infection
Riverside University Health System Medical Center176 enrolled1 locationNCT07221370
Recruiting
Not Applicable

Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract

Carbapenem-Resistant EnterobacteriaceaeVancomycin (Glycopeptide) Resistant Enterococcus (VRE)
Chuncheon Sacred Heart Hospital240 enrolled2 locationsNCT06001333
Recruiting
Not Applicable

Safety and Efficacy of Fecal Microbiota Transplantation

AlopeciaDiabetes MellitusObesity+18 more
Chinese University of Hong Kong450 enrolled1 locationNCT04014413
Recruiting

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units

Cross InfectionCritical IllnessCarbapenem Resistant Bacterial Infection+1 more
Abderrahmane Mami Hospital500 enrolled1 locationNCT06392568
Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Antibiotic Resistant InfectionCarbapenem-Resistant Enterobacteriaceae InfectionVancomycin Resistant Enterococci Infection+5 more
The Methodist Hospital Research Institute1,000 enrolled2 locationsNCT06258551
Recruiting

Analgesic, Sedative and Antibiotic Pharmacokinetics during Extracorporeal Membrane Oxygenation: Understanding altered pharmacokinetics to improve patient outcomes.

Alterations to the pharmacokinetics of broad spectrum antibiotics (ceftriaxone, cefepime, meropenem, gentamicin, ciprofloxacin, ticarcillin-clavulanate, piperacillin-tazobactum, vancomycin, linezolid, caspofungin, fluconazole, voriconazole, oseltamivir/oseltamivir carboxylate) in critically ill patients receiving ECMO.Alterations to the pharmacokinetics of sedative and analgesic drugs and their metabolites (morphine - morphine 3 glucorunide, morphine 6 glucuronide, midazolam - 1 and 4 hydroxy midazolam, fentanyl - norfentanyl, dexmedetiomedine, propofol, thiopentone) in critically ill patients receiving ECMO.
Critical Care Research Group160 enrolled4 locationsACTRN12612000559819